 |
杜传军主任医师现任浙江大学医学院附属第二医院泌尿外科主任,中华泌尿外科学会尿控女性泌尿外科学组委员、中国医师协会泌尿外科腔镜学组委员、中华中西医结合泌尿外科学会常务委员、浙江省医学会泌尿外科学会副主任委员、专家委员会委员、浙江省抗癌协会委员。
杜传军主任自1982年起从事泌尿外科临床工作,擅长泌尿系肿瘤、结石、前列腺增生等泌尿外科疾病的诊治,手术技能享誉浙江省泌尿外科学界。十余年前即在省内首先主持开展了输尿管镜气压弹道碎石、钬激光碎石手术;在国内率先开展钬激光前列腺剜除术,各类泌尿外科腹腔镜手术、微创经皮肾镜钬激光碎石取石术等,是国内泌尿外科腔镜手术著名专家。近年来重点研究泌尿系恶性肿瘤的诊断与治疗、前列腺癌的根治手术、内分泌治疗以及同位素近距离放射治疗,及各类内窥镜技术在泌尿外科的临床应用,积累了近万例泌尿外科腔镜手术、疑难手术的成功经验。
杜传军主任2002年作为中华泌尿外科将才工程首批选送人才赴美国南加州大学学习。历年来共发表科研论文20余篇,主持或参与各类研究课题7项,参与编写著作2部,获得多项省级科技成果奖,并多次赴美国、欧洲、日本等国家进行学术交流。
专家门诊时间:周一上午,周三上午。
电话:0571-87783573
E-mail: chuanjundu@hotmail.com
Chuanjun Du, M.D
Chair of Department of Urology, Second affliated Hospital of Zhejiang University, School of Medicine
Medical School (the highest level degree)
Zhejiang University, School of Medicine, Hangzhou, Zhejiang
Academic Rank
Professor of Urology
Interests
Ureteroscopic pneumatic and holmium laser lithotripsy, holmium laser enucleation of prostate, radical prostatectomy and laparoscopic urological surgery. His research interest also focuses on prostate cancer treatment including brachytherapy and hormonal therapy, as well as the application of various endoscopic techniques in urological surgery.
Honours
2nd prize of Provincial Science and technology advancement in 2005 by project “the Efficacy and Safety of Holmium Laser Enucleation of Prostate”
Professional Highlights
Committee member of endo-urology division of Chinese Urological Association.
Committee member of endo-urology division of Chinese Association of Physicians.
Vice-president of committee panel of Zhejiang Chinese Urological Association.
Reasearch Support
Completed Research Support
Provincial Science and Technology Grant, Chuanjun Du (PI) 1/1/02-12/31/04
the Efficacy and Safety of Holmium Laser Enucleation of Prostate
Role: Principal Investigator
Publications
Gong Y, Du C, Josephson DY, Wilson TG, Nelson R. Four-arm robotic partial nephrectomy for complex renal cell carcinoma. World J Urol. 2010 Feb;28(1):111-5.
Zhang Y, Chen ZD, Du CJ, Xu G, Luo W. siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells. Pathol Res Pract. 2009;205(12):823-7.
Zhu J, Liu XM, Du CJ, Zhang ZW, Qiu YQ, Gong Y, Liu JR, Hong YR, Luo ZY, Zhang Y. Diagnostic value of lesion-directed prostate biopsy under TRUS in early detection of prostate cancer. Zhonghua Nan Ke Xue. 2009 May;15(5):437-40.
Shen XC, Gu CX, Qiu YQ, Du CJ, Fu YB, Wu JJ. Estrogen receptor expression in adrenocortical carcinoma. J Zhejiang Univ Sci B. 2009 Jan;10(1):1-6.
Du C, Jin X, Bai F, Qiu Y. Holmium laser enucleation of the prostate: the safety, efficacy, and learning experience in China. J Endourol. 2008 May;22(5):1031-6.
Shen XC, DU CJ, Chen JM, Zhang ZW, Qiu YQ. Splenogonadal fusion. Chin Med J (Engl). 2008 Feb 20;121(4):383-4.
Shen XC, Du CJ, Chen JM. Case report: splenogonadal fusion. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 May;36(3):1 p.
Zhang Y, Du CJ, Xu G, Chen JM, Jing X. Transurethral holmium laser enucleation for prostate adenoma greater than 100 g. Zhonghua Nan Ke Xue. 2007 Dec;13(12):1091-3.
Gong Y, Du CJ, Ding LL, Song B, Jin XY. Inhibition on phenotypic transformation of detrusor smooth muscle cells after bladder outlet obstruction by E2F decoy strategy. Zhonghua Yi Xue Za Zhi. 2007 Mar 27;87(12):829-32.
Qiu Y, DU C, Shen X. Transurethral resection in women with lower urinary tract symptoms. Int J Urol. 2004 Dec;11(12):1097-103.
Tel: 0571-87783573, E-mail: chuanjundu@hotmail.com
|